Bristol-Myers Squibb to buy drugmaker Celgene for $74 billion

Bristol-Myers Squibb to buy drugmaker Celgene for $74 billion
Bristol-Myers Squibb announced Thursday that it is buying Celgene for $74 billion, creating a merger of two giant pharmaceutical companies. Bristol-Myers Squibb said the move would expand its portfolio of drugs and enhance its pipeline of those in...

Source: http://bit.ly/2GOC2q6